###begin article-title 0
###xml 82 90 <span type="species:ncbi:9606">patients</span>
Mutation screening and haplotype analysis of the rhodopsin gene locus in Japanese patients with retinitis pigmentosa
###end article-title 0
###begin title 1
Purpose
###end title 1
###begin p 2
###xml 83 91 <span type="species:ncbi:9606">patients</span>
To identify nucleotide sequence variations in the rhodopsin (RHO) gene of Japanese patients with retinitis pigmentosa (RP) in order to search for mutations or haplotypes responsible for RP.
###end p 2
###begin title 3
Methods
###end title 3
###begin p 4
###xml 21 24 21 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
###xml 139 147 <span type="species:ncbi:9606">patients</span>
The entire region of RHO locus including a promoter region and introns was sequenced using blood-derived genomic DNA samples donated by 68 patients with RP and 68 control subjects.
###end p 4
###begin title 5
Results
###end title 5
###begin p 6
###xml 253 256 253 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
###xml 542 545 542 545 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
###xml 600 608 <span type="species:ncbi:9606">patients</span>
We found 39 single nucleotide substitutions including 17 rare substitutions of less than 1% in frequency, one insertion/deletion polymorphism, and one CA-repeat polymorphism in a 7.8 kbp region spanning the promoter, five exons, and four introns of the RHO gene locus. There were no affected subjects with amino acid substitutions in RHO, and there was 1 control subject with a novel substitution (Ala42Thr) who had no symptoms of RP. Fine analysis of single nucleotide polymorphism (SNPs) revealed eight haplotype structures of the Japanese RHO locus. There was no significant difference between RP patients and controls in terms of haplotype frequency.
###end p 6
###begin title 7
Conclusions
###end title 7
###begin p 8
###xml 177 180 177 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
###xml 82 90 <span type="species:ncbi:9606">patients</span>
###xml 391 399 <span type="species:ncbi:9606">patients</span>
No mutation causing an amino acid substitution of RHO was observed in 68 Japanese patients with RP, but 1 control subject did have a novel amino acid substitution. The Japanese RHO locus is comprised of eight major haplotypes. The RP-associated haplotype was not identified. The haplotype-tagging SNPs identified in this study will be useful as markers for the linkage-based screening of RP patients.
###end p 8
###begin title 9
Introduction
###end title 9
###begin p 10
###xml 183 184 183 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 328 329 328 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r2">2</xref>
###xml 568 569 568 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r3">3</xref>
###xml 570 571 570 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
###xml 746 747 746 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r5">5</xref>
###xml 852 853 852 853 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r6">6</xref>
###xml 237 244 <span type="species:ncbi:9606">persons</span>
###xml 842 850 <span type="species:ncbi:9606">patients</span>
Retinitis pigmentosa (RP) is a group of hereditary retinal diseases characterized by night blindness and progressive loss of the visual field. It has a prevalence of about 1 in 4000 [1]. RP was the major cause of visual impairment among persons who entered 29 rehabilitation centers in Japan, accounting for 25% of these cases [2]. RP is a disease with considerable genetic heterogeneity; it is transmitted as an autosomal dominant, autosomal recessive, X-linked, or rare mitochondrial form. Moreover, digenic or syndromic forms of RP complicate inheritance patterns [3,4]. The frequency of the inherited type has been estimated as follows: 19% dominant, 65% recessive or isolated, 8% X-linked, and 8% undetermined in Maine in the United States [5]; 16.9% dominant, 25.2% recessive, 1.6% X-linked, and 56.3% simplex in a study of Japanese RP patients [6].
###end p 10
###begin p 11
###xml 109 110 109 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r3">3</xref>
###xml 342 343 342 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r7">7</xref>
###xml 344 345 344 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 354 357 354 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
###xml 396 398 396 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r10">10</xref>
###xml 468 471 468 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
###xml 479 480 479 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 481 482 481 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r7">7</xref>
###xml 483 484 483 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 628 630 628 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 631 633 631 633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 677 679 677 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 680 682 680 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 802 804 802 804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r16">16</xref>
###xml 817 819 817 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
###xml 833 835 833 835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 849 851 849 851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 865 867 865 867 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
###xml 1005 1007 1005 1007 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
###xml 716 724 <span type="species:ncbi:9606">patients</span>
So far, positional cloning and candidate gene screening have identified at least 36 loci responsible for RP [3] (for the latest summary, see the  page). Of the genes known to cause autosomal dominant RP (adRP) in the United States and Canada, mutations in a rhodopsin (RHO) gene were most frequently observed, accounting for 24-29% of cases [7-9]. Since RHO was identified as an RP-causing gene [10], a number of mutations have been found at a variety of sites on the RHO locus [1,7-9] (for the latest summary, see ). Most rhodopsin mutations cause adRP, whereas a few have been reported to cause autosomal recessive RP (arRP) [11,12] or congenital stationary night blindness [13-15]. In a total of 85 Japanese adRP patients, the following five causative mutations in RHO have been reported: Asn15Ser [16], Thr17Met [17], Gly106Arg [18], Glu181Lys [19], Pro347Leu [17]. The rate of RHO mutations in Japanese (5/85, 5.9%) is lower than that in the United States, suggesting a race-dependent mutation rate [20].
###end p 11
###begin p 12
###xml 143 144 143 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r7">7</xref>
###xml 145 146 145 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 147 149 147 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 345 348 345 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
###xml 350 352 350 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 449 452 449 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
###xml 792 794 789 791 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 829 832 826 829 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
###xml 951 954 948 951 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
###xml 988 991 985 988 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
###xml 1009 1011 1006 1008 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
###xml 1073 1076 1070 1073 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
A single-stranded conformation polymorphism method targeting the coding regions has been frequently used for the first screening of mutations [7-9,11], but this method intrinsically includes the possibility of missing mutations. Mutations in a promoter region or introns may also be responsible for arRP by affecting the levels of expression of RHO [13]. These problems with mutation screening can be resolved by sequencing the entire region of the RHO locus. Furthermore, full sequencing provides information about single nucleotide polymorphism (SNPs) and haplotypes that could affect the expression levels of the gene. Promoter haplotype combinations have been shown to affect the biological and therapeutic phenotypes by altering the expression of the gene for beta2-adrenergic receptor [21]. This led us to hypothesize that RHO promoter haplotypes are associated with susceptibility to RP via a mechanism that changes the levels of expression of RHO. A search for RP-related SNPs in RHO was carried out [22], but there has been no report on the haplotype structure of RHO to date.
###end p 12
###begin p 13
###xml 61 64 61 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
###xml 188 191 188 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
###xml 203 211 <span type="species:ncbi:9606">patients</span>
In the present study, we determined the full sequence of the RHO locus, including the promoter regions and introns, in order to search for RP-associated mutations and/or haplotypes in the RHO loci of RP patients who visited the low-vision clinic at our center.
###end p 13
###begin title 14
Methods
###end title 14
###begin title 15
Subjects
###end title 15
###begin p 16
###xml 294 301 294 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 27 35 <span type="species:ncbi:9606">patients</span>
###xml 146 153 <span type="species:ncbi:9606">patient</span>
###xml 195 203 <span type="species:ncbi:9606">patients</span>
###xml 389 397 <span type="species:ncbi:9606">patients</span>
###xml 457 464 <span type="species:ncbi:9606">patient</span>
###xml 600 608 <span type="species:ncbi:9606">patients</span>
###xml 1050 1055 <span type="species:ncbi:9606">Human</span>
###xml 1122 1129 <span type="species:ncbi:9606">Persons</span>
We studied 68 unrelated RP patients who visited the low-vision clinic at our center. RP subjects were selected on the basis of clinical findings, patient history, and family history. Of these 68 patients, 26 had a family history, 27 had no family history, and 15 had an unknown family history. Table 1 shows the detailed information on the 26 subjects with a family history. Five of these patients had an affected parent with RP or night blindness, and the patient designated as RP048 reported having an affected sibling whose son suffers from RP. Thus, these six cases were diagnosed as adRP. Seven patients with grandparents or cousins with RP or night blindness could have suffered from adRP. RP051 and RP062 reported a family history of consanguineous marriage. Control samples were obtained from students at the college affiliated with our center and from members of our staff of the center, all of whom declared having neither a personal history nor a family history of night blindness or unexplained visual loss. The study was approved by the Human Genome-Ethics Committee of the National Rehabilitation Center for Persons with Disabilities and was performed in accordance with the Declaration of Helsinki. Informed consent was obtained from all subjects involved in this study.
###end p 16
###begin title 17
###xml 36 44 <span type="species:ncbi:9606">patients</span>
Information on retinitis pigmentosa patients with a family history.
###end title 17
###begin p 18
###xml 19 27 <span type="species:ncbi:9606">patients</span>
Of 68 unrelated RP patients who visited the low-vision clinic at our center, 26 had a family history. Sex: Male (M), Female (F). Siblings and affected siblings include the proband. NB indicates night blindness. Inheritance type: ad indicates autosomal dominant; ar indicates autosomal recessive.
###end p 18
###begin title 19
DNA sample preparation
###end title 19
###begin p 20
###xml 253 256 253 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
###xml 365 368 365 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
###xml 453 460 453 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2">Table 2</xref>
###xml 553 556 553 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
###xml 618 621 618 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
Genomic DNA was isolated from venous blood using a PUREGENE DNA purification Kit (Gentra Systems, Minneapolis, MN). A sample for DNA sequencing was prepared by polymerase chain reaction (PCR) using genomic DNA as a template. The genomic sequence of the RHO locus (NT_005612.15) was retrieved from NCBI database (Build 36.1). Nucleotide A of the initiation codon of RHO was defined as Position 1. The primer sequences for PCR amplification are listed in Table 2. The first PCR amplification was performed in order to obtain two amplicons, A1 (containing RHO exons and introns) and A2 (containing the promoter region of RHO). Two hundred nanograms of genomic DNA were amplified with Taq polymerase (TaKaRa Ex Taq(R) Takara Bio Inc., Shiga, Japan) in a 50 mul reaction volume for 30 cycles under conditions of heating for 30 s at 96 degreesC, annealing for 30 s at 63 degreesC, and extension for 2 min at 72 degreesC. The second PCR amplification using amplicon A1 as a template produced 4 amplicons (A3, A4, A5, A6).
###end p 20
###begin title 21
###xml 58 67 58 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rhodopsin</italic>
Polymerase chain reaction primers used for amplifying the rhodopsin gene locus.
###end title 21
###begin p 22
Position 1 corresponds to the nucleotide A of the initiation codon of the RHO gene. Lower letters represent an artificial sequence added for cloning the polymerase chain reaction products.
###end p 22
###begin title 23
Sequencing
###end title 23
###begin p 24
###xml 160 167 158 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3">Table 3</xref>
PCR products were sequenced bi-directionally with a BigDye(R) Terminator Cycle Sequencing Kit (Applied Biosystems, Foster City, CA) using the primers listed in Table 3. Sequencing reaction products were run on an automated capillary sequencer (Applied Biosystems 3130xl Genetic Analyzer, Applied Biosystems, Foster City, CA).
###end p 24
###begin title 25
Primers used for sequencing.
###end title 25
###begin p 26
###xml 74 77 74 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
Position 1 corresponds to the nucleotide A of the initiation codon of the RHO gene.
###end p 26
###begin title 27
Haplotype analysis
###end title 27
###begin p 28
###xml 75 77 75 77 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r23">23</xref>
###xml 128 130 128 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r24">24</xref>
###xml 222 224 222 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r25">25</xref>
Haplotypes were estimated from unphased genotypes using Clark's algorithm [23] and the expectation-maximization (EM) algorithm [24]. Phylogenetic analysis was carried out with the minimum spanning network (MSN) algorithm [25]. The Arlequin program (Schneider, Roessli, Excoffier,  version 2.000: A software for population genetics data analysis, Geneva, Switzerland) was used for the analysis using the EM algorithm and the MSN algorithm.
###end p 28
###begin title 29
Results
###end title 29
###begin title 30
Sequence variations
###end title 30
###begin p 31
###xml 0 7 0 7 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t4">Table 4</xref>
###xml 290 298 <span type="species:ncbi:9606">patients</span>
###xml 747 755 <span type="species:ncbi:9606">patients</span>
Table 4 shows the sequence variations obtained in this study. We identified a total of 41 sequence variations consisting of 39 single nucleotide substitutions, one insertion/deletion polymorphism (Indel, SV15), and one CA-repeat polymorphism (SV16) in a total of 272 chromosomes from 68 RP patients and 68 controls. Of 39 single nucleotide substitutions, 25 sites were novel ones not registered in the dbSNP database (National Center of Biotechnology Information). This study did not find four substitutions (rs2855553, rs2855556, rs2625964, rs2625969) registered in the dbSNP, which seem to be rare among Japanese. Rare substitutions with less than 1% minor allele frequency (MAF) occurred at 17 sites, nine of which were observed only in the RP patients and six only in the controls.
###end p 31
###begin title 32
###xml 47 56 47 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rhodopsin</italic>
Nucleotide sequence variations observed in the rhodopsin gene locus.
###end title 32
###begin p 33
###xml 135 143 <span type="species:ncbi:9606">patients</span>
###xml 145 147 <span type="species:ncbi:9606">RP</span>
The amino acid substitution caused by nucleotide substitution was represented in parenthesis. Individual SNPs were characterized in 68 patients (RP) and 68 controls (Ctl). A database of Japanese single nucleotide polymorphisms (JSNP) contains nine SNPs that were measured in 732-746 Japanese subjects.
###end p 33
###begin p 34
###xml 669 671 <span type="species:ncbi:9606">RP</span>
###xml 672 679 <span type="species:ncbi:9606">patient</span>
###xml 770 772 <span type="species:ncbi:9606">RP</span>
###xml 773 781 <span type="species:ncbi:9606">patients</span>
Twenty substitutions with a MAF of greater than 1% showed linkage disequilibrium (LD) between pairs, and these substitutions were designated as SNP01 to SNP20. These SNPs were consistent with the Hardy-Weinberg equilibrium (data not shown). SV14 and SV27 exhibited 1.5% of the MAF, but were excluded from the SNPs due to the absence of LD pairs. Most SNPs with a MAF of greater than 10% were registered in the dbSNP, with the exception of SNP11. Nine SNPs were registered in a database of Japanese single nucleotide polymorphisms () and the MAF values of these substitutions were similar to each other at each site, except in the case of SNP20. The differences between RP patient and control MAFs were small, except in the case of SNP20. The MAF at SNP20 was 8.8% among RP patients and 19.9% among controls, respectively. However, the mean MAF of all subjects at SNP20 was 14.4%, which is similar to the value described in the JSNP database, i.e., 15.1% (1488 chromosomes).
###end p 34
###begin p 35
###xml 368 370 368 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r26">26</xref>
###xml 278 280 <span type="species:ncbi:9606">RP</span>
###xml 281 288 <span type="species:ncbi:9606">patient</span>
Four rare single nucleotide substitutions were observed in the coding region. Three substitutions (SV07, SV08, and SV27) were synonymous. On the other hand, SV06 observed in 1 control led to an amino acid substitution (Ala42Thr). SV03 was observed in the promoter region of one RP patient, and it was located at position -503 upstream of the transcription start site [26].
###end p 35
###begin p 36
Intron 1 was found to contain an Indel of 10bp (SV15) followed by a CA-repeat polymorphism (SV16, (CA)nA(CA)m, n=12-14, m=15-27). The precise number of repeats was not determined due to degeneration of sequences.
###end p 36
###begin title 37
Haplotypes
###end title 37
###begin p 38
###xml 18 21 18 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
###xml 217 224 217 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t5">Table 5</xref>
###xml 100 108 <span type="species:ncbi:9606">patients</span>
###xml 948 950 <span type="species:ncbi:9606">RP</span>
###xml 951 959 <span type="species:ncbi:9606">patients</span>
Haplotypes of the RHO locus were estimated on the basis of 20 SNPs of 272 chromosomes obtained from patients and controls. Indel variation SV15 was also taken into account, because it was found to be linked to SNP11. Table 5 shows 14 haplotypes consisting of eight major haplotypes and six rare ones. The rare haplotypes (H09-H14) appeared to be the result of a single conversion in the corresponding major haplotype. There were five groups of LD structures of SNPs and an Indel: SNP01-SNP02-SNP04-SNP14-SNP18, SNP06-SNP09-SNP12-SNP13-SNP16, SNP07-SNP15, SNP08-SNP10-SNP19, and SNP11-SV15. Eight major haplotypes can produce 36 combinations, in which 29 were identified in 136 subjects. Seven major haplotypes, except for H08, were found to exist as a homozygote. The most frequent haplotype, H01, accounted for 27.2% of a total of 272 chromosomes. The present comparison of haplotype frequencies did not reveal any significant differences between RP patients and controls when taking into account the multiple comparisons. With a Bonferroni correction for the eight comparisons, a p-value of 0.05/8=0.006 is required for statistical significance.
###end p 38
###begin title 39
###xml 27 36 27 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rhodopsin</italic>
Haplotypes of the Japanese rhodopsin gene locus.
###end title 39
###begin p 40
###xml 61 69 <span type="species:ncbi:9606">patients</span>
###xml 71 73 <span type="species:ncbi:9606">RP</span>
A total of 136 subjects comprised of 68 retinitis pigmentosa patients (RP) and 68 controls (Ctr) were analyzed. One insertion/deletion (Indel) variation was linked to SNP11. Red letters represent haplotype-tagging SNPs.
###end p 40
###begin title 41
###xml 13 22 13 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rhodopsin</italic>
Phylogeny of rhodopsin gene haplotypes
###end title 41
###begin p 42
###xml 17 20 17 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
###xml 93 101 93 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1</xref>
###xml 405 413 405 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1</xref>
###xml 429 432 429 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
###xml 709 717 709 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1</xref>
###xml 192 194 <span type="species:ncbi:9606">RP</span>
###xml 195 203 <span type="species:ncbi:9606">patients</span>
The phylogeny of RHO haplotypes was calculated using the minimum spanning network algorithm (Figure 1). The area of the circle is proportional to the frequency of each haplotype. The ratio of RP patients (orange) and controls (light blue) for each haplotype is color-coded. The number of line segments between circles corresponds to the number of nucleotide substitutions between haplotypes. The graph in Figure 1 shows that the RHO haplotypes can be classified into five groups separated by a large number of nucleotide substitutions. The groups are designated as Group I to Group V. The haplotype-tagging SNP (htSNP) distinguishing each group is described in the parenthesis following the group name in the Figure 1. Furthermore, the htSNP distinguishing each haplotype in the group is described in parenthesis following the haplotype name. These htSNPs can be used as markers to estimate the haplotype of new subjects.
###end p 42
###begin p 43
###xml 22 31 22 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rhodopsin</italic>
###xml 341 344 341 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
###xml 137 139 <span type="species:ncbi:9606">RP</span>
###xml 140 148 <span type="species:ncbi:9606">patients</span>
Phylogeny of Japanese rhodopsin gene haplotypes. The area of the circle is proportional to the frequency of each haplotype. The ratio of RP patients (orange) and controls (light blue) for each haplotype is color-coded. The number of line segments between circles corresponds to the number of nucleotide substitutions between haplotypes. The RHO haplotypes can be classified into five groups designated as Group I to Group V. The haplotype-tagging SNP (htSNP) distinguishing each group is described in the parentheses following the group name and the haplotype name.
###end p 43
###begin title 44
Discussion
###end title 44
###begin p 45
###xml 212 214 212 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r16">16</xref>
###xml 215 217 215 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 875 877 875 877 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r27">27</xref>
###xml 928 930 928 930 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r28">28</xref>
###xml 108 110 <span type="species:ncbi:9606">RP</span>
###xml 111 119 <span type="species:ncbi:9606">patients</span>
###xml 202 210 <span type="species:ncbi:9606">patients</span>
###xml 427 435 <span type="species:ncbi:9606">patients</span>
###xml 784 792 <span type="species:ncbi:9606">patients</span>
In this study, we did not detect any causative mutation in the coding region of the RHO gene of 68 Japanese RP patients. Five mutations in RHO have been reported to date for a total of 85 Japanese adRP patients [16-19]; thus, the prevalence of causative mutations in RHO is calculated to be 5.9%, suggesting that RHO mutations may be among the common causes of adRP in Japan. Based on the estimated number (at most 13) of adRP patients in this study, the predicted number of cases with a RHO mutation was less than 1. Thus, the present results are consistent with those of previous studies, indicating that the rate of RHO mutations in Japanese adRP is low compared to that of the American population. It should be noted that more frequent occurrence of RHO mutations in the American patients is partially due to the presence of a large number of families carrying Pro23His [27], which likely originated from a single ancestor [28].
###end p 45
###begin p 46
###xml 565 567 565 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r29">29</xref>
###xml 826 828 826 828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r30">30</xref>
###xml 1388 1389 1388 1389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 1403 1405 1403 1405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r31">31</xref>
###xml 1419 1421 1419 1421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r27">27</xref>
###xml 1439 1441 1439 1441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r32">32</xref>
###xml 1514 1516 1514 1516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 791 798 <span type="species:ncbi:9606">patient</span>
###xml 822 824 <span type="species:ncbi:9606">RP</span>
###xml 1510 1512 <span type="species:ncbi:9606">RP</span>
Unexpectedly, one novel heterozygous variation causative of an amino acid substitution (Ala42Thr) was found in 1 control subject. This variation exists in the first transmembrane domain. To date, eleven pathogenic variations have been reported in the first transmembrane domain of . The Ala residue at position 42 is fairly conserved among vertebrate opsins. Of 143 reported vertebrate opsin sequences, 130 have an Ala at position 42, whereas 12 have Cys and 1 has Ser at that position (GPCRDB: Information system for G protein-coupled receptors (), release 10.0) [29]. The amino acid change from a nonpolar Ala to a polar and slightly larger Thr could affect the conformation of the first transmembrane domain. A similar substitution close to the 42nd Ala, Met44Thr, has been reported in a patient with a simplex case of RP [30]. These findings suggest that Ala42Thr could be a pathogenic mutation. However, the control subjects reported having no symptoms such as night blindness or other visual impairments, nor was there any family history of visual impairments. There are three possibilities that might account for the discrepancy between the predicted pathogenic phenotype and the apparently silent phenotype of the carrier. The first possibility would be that Ala42Thr is a rare benign variation. In fact, four nonpathogenic missense changes have been reported thus far: Thr70Met [9], Val104Ile [31], Pro220Leu [27], and Gly284Ser [32]. On the other hand, a missense change, Glu150Lys, caused recessive RP [12], and this second possibility suggests that the Ala42Thr change might be a recessive mutation. The third possibility would be that the symptoms were sufficiently mild to escape the notice of the carrier. Unfortunately, this issue remains unsolved, as we were unable to obtain any clinical information on this subject.
###end p 46
###begin p 47
###xml 23 26 23 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
###xml 474 477 474 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
###xml 488 490 488 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r33">33</xref>
###xml 630 632 630 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r34">34</xref>
###xml 758 760 758 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r35">35</xref>
###xml 160 162 <span type="species:ncbi:9606">RP</span>
###xml 163 171 <span type="species:ncbi:9606">patients</span>
###xml 467 473 <span type="species:ncbi:9913">bovine</span>
###xml 515 521 <span type="species:ncbi:9913">bovine</span>
Full sequencing of the RHO locus has revealed the presence of variations in the promoter region and introns. Seven heterozygous variations occurred only in the RP patients: 1 in the promoter region, 4 in the introns, and 2 in the 3'-UTR. Although we cannot deny the possibility of causative mutations, most cases may be rare variations. SV03 is located at position -503 upstream of the transcription start site. This region did not show significant homology with the bovine RHO promoter [33], and the corresponding bovine sequence was not included in the protected regulatory elements determined by DNase I footprint experiments [34]. We were also unable to identify regulatory elements for retina-specific transcription factors such as CRX, NRL, and NR2E3 [35] in this region. These results suggest that SV03 is unlikely to affect promoter activity. This issue should be resolved in future experiments by measuring the promoter activity of SV03 variants.
###end p 47
###begin p 48
###xml 72 75 72 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
###xml 449 450 449 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
The fine mapping of SNPs has revealed eight haplotype structures of the RHO locus in the Japanese population. The haplotypes obtained are classified into five groups that may stem from distinct Japanese ancestors. If a causative mutation is associated with a specific haplotype, it may stem from a single ancestor. From this perspective, it would be of interest to determine which haplotypes carry frequent mutations such as Pro23His and Pro347Leu [8].
###end p 48
###begin p 49
###xml 210 213 210 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
###xml 522 525 522 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
###xml 42 44 <span type="species:ncbi:9606">RP</span>
###xml 167 169 <span type="species:ncbi:9606">RP</span>
###xml 402 404 <span type="species:ncbi:9606">RP</span>
###xml 405 413 <span type="species:ncbi:9606">patients</span>
###xml 511 513 <span type="species:ncbi:9606">RP</span>
Unfortunately, we were unable to identify RP-associated SNPs or haplotypes. Our first expectation was that the haplotype of the promoter region may be associated with RP by altering the levels of expression of RHO. The promoter region contains five SNPs (SNP01-SNP05) that construct four haplotypes. Assessment of frequencies of these four haplotypes did not reveal any significant differences between RP patients and controls (data not shown), suggesting that there is no association between susceptibility to RP and the RHO promoter haplotype.
###end p 49
###begin p 50
###xml 122 125 122 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
###xml 201 204 201 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
###xml 233 241 <span type="species:ncbi:9606">patients</span>
###xml 247 249 <span type="species:ncbi:9606">RP</span>
###xml 388 390 <span type="species:ncbi:9606">RP</span>
###xml 510 512 <span type="species:ncbi:9606">RP</span>
###xml 513 521 <span type="species:ncbi:9606">patients</span>
In conclusion, this was the first study to determine the comprehensive sequence variations and haplotype structure of the RHO locus, including the promoter region and introns. No causative mutation in RHO was observed in 68 Japanese patients with RP, but 1 control subject had a novel amino acid substitution, Ala42Thr, which may have been benign. Although we were unable to identify any RP-associated SNPs or haplotypes, the htSNPs identified here will be useful as markers for the linkage-based screening of RP patients.
###end p 50
###begin title 51
Acknowledgements
###end title 51
###begin p 52
This work was supported by a grant from the Ministry of Health, Labor and Welfare of Japan.
###end p 52
###begin title 53
References
###end title 53
###begin article-title 54
Retinitis pigmentosa. The Friedenwald Lecture.
###end article-title 54
###begin article-title 55
###xml 57 64 <span type="species:ncbi:9606">persons</span>
Causes of entering institutions for visually handicapped persons during the past fifteen years.
###end article-title 55
###begin article-title 56
A brief review of retinitis pigmentosa and the identified retinitis pigmentosa genes.
###end article-title 56
###begin article-title 57
Retinitis pigmentosa and allied diseases: numerous diseases, genes, and inheritance patterns.
###end article-title 57
###begin article-title 58
Prevalence of retinitis pigmentosa in Maine.
###end article-title 58
###begin article-title 59
Multicenter genetic study of retinitis pigmentosa in Japan: I. Genetic heterogeneity in typical retinitis pigmentosa.
###end article-title 59
###begin article-title 60
Rhodopsin mutations in autosomal dominant retinitis pigmentosa.
###end article-title 60
###begin article-title 61
###xml 46 54 <span type="species:ncbi:9606">patients</span>
Mutation spectrum of the rhodopsin gene among patients with autosomal dominant retinitis pigmentosa.
###end article-title 61
###begin article-title 62
Prevalence of disease-causing mutations in families with autosomal dominant retinitis pigmentosa: a screen of known genes in 200 families.
###end article-title 62
###begin article-title 63
A point mutation of the rhodopsin gene in one form of retinitis pigmentosa.
###end article-title 63
###begin article-title 64
A null mutation in the rhodopsin gene causes rod photoreceptor dysfunction and autosomal recessive retinitis pigmentosa.
###end article-title 64
###begin article-title 65
###xml 55 57 <span type="species:ncbi:9606">RP</span>
Missense rhodopsin mutation in a family with recessive RP.
###end article-title 65
###begin article-title 66
Heterozygous missense mutation in the rhodopsin gene as a cause of congenital stationary night blindness.
###end article-title 66
###begin article-title 67
###xml 46 51 <span type="species:ncbi:9606">human</span>
Dark-light: model for nightblindness from the human rhodopsin Gly-90-->Asp mutation.
###end article-title 67
###begin article-title 68
A novel mutation within the rhodopsin gene (Thr-94-Ile) causing autosomal dominant congenital stationary night blindness.
###end article-title 68
###begin article-title 69
Missense mutation of rhodopsin gene codon 15 found in Japanese autosomal dominant retinitis pigmentosa.
###end article-title 69
###begin article-title 70
Point mutations of rhodopsin gene found in Japanese families with autosomal dominant retinitis pigmentosa (ADRP).
###end article-title 70
###begin article-title 71
Rhodopsin gene codon 106 mutation (Gly-to-Arg) in a Japanese family with autosomal dominant retinitis pigmentosa.
###end article-title 71
###begin article-title 72
Autosomal dominant retinitis pigmentosa. A mutation in codon 181 (Glu-->Lys) of the rhodopsin gene in a Japanese family.
###end article-title 72
###begin article-title 73
A study on the rhodopsin gene in Japanese retinitis pigmentosa--screening of mutation by restriction endonucreases and frequencies of DNA polymorphisms.
###end article-title 73
###begin article-title 74
Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness.
###end article-title 74
###begin article-title 75
Frequencies of polymorphisms in the rhodopsin gene of Japanese retinitis pigmentosa and normal individuals.
###end article-title 75
###begin article-title 76
Inference of haplotypes from PCR-amplified samples of diploid populations.
###end article-title 76
###begin article-title 77
Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population.
###end article-title 77
###begin article-title 78
###xml 99 104 <span type="species:ncbi:9606">human</span>
Analysis of molecular variance inferred from metric distances among DNA haplotypes: application to human mitochondrial DNA restriction data.
###end article-title 78
###begin article-title 79
###xml 55 60 <span type="species:ncbi:9606">human</span>
Isolation and nucleotide sequence of the gene encoding human rhodopsin.
###end article-title 79
###begin article-title 80
Novel rhodopsin mutations Gly114Val and Gln184Pro in dominant retinitis pigmentosa.
###end article-title 80
###begin article-title 81
###xml 39 47 <span type="species:ncbi:9606">patients</span>
Mutations within the rhodopsin gene in patients with autosomal dominant retinitis pigmentosa.
###end article-title 81
###begin article-title 82
GPCRDB: an information system for G protein-coupled receptors.
###end article-title 82
###begin article-title 83
Identification of a novel rhodopsin mutation (Met-44-Thr) in a simplex case of retinitis pigmentosa.
###end article-title 83
###begin article-title 84
Identification of novel rhodopsin mutations responsible for retinitis pigmentosa: implications for the structure and function of rhodopsin.
###end article-title 84
###begin article-title 85
###xml 22 28 <span type="species:ncbi:9913">bovine</span>
###xml 90 95 <span type="species:ncbi:10090">mouse</span>
Unusual topography of bovine rhodopsin promoter-lacZ fusion gene expression in transgenic mouse retinas.
###end article-title 85
###begin article-title 86
###xml 50 56 <span type="species:ncbi:9913">bovine</span>
Developmentally important DNA elements within the bovine opsin upstream region.
###end article-title 86
###begin article-title 87
Identification of regulatory targets of tissue-specific transcription factors: application to retina-specific gene regulation.
###end article-title 87

